Cyclo Therapeutics, Inc. (CYTHW) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Gainesville, FL, アメリカ. 現CEOは N. Scott Fine.
CYTHW を有する IPO日 2020-12-18, 8 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $899.37K.
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
